These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19288792)

  • 21. Drug & alcohol testing. Oral fluid testing update.
    Andrie M
    Occup Health Saf; 2001 Aug; 70(8):32-4. PubMed ID: 11523283
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug testing in the workplace: integrating medical review officer duties into occupational medicine.
    Smith DE; Glatt W; Tucker DE; Deutsch R; Seymour RB
    Occup Med; 2002; 17(1):79-90, v. PubMed ID: 11726338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective drug-free workplace plan uses worker testing as a deterrent.
    Quazi MM
    Occup Health Saf; 1993 Jun; 62(6):26-7, 29-32. PubMed ID: 8327243
    [No Abstract]   [Full Text] [Related]  

  • 24. A protocol to evaluate drug-related workplace impairment.
    Reisfield GM; Shults T; Demery J; Dupont R
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):43-8. PubMed ID: 23527668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-free workplace programmes: New Zealand perspective.
    Nolan S
    Forensic Sci Int; 2008 Jan; 174(2-3):125-32. PubMed ID: 17467938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Finnish legislation on workplace drug testing.
    Lamberg ME; Kangasperko R; Partinen R; Lillsunde P; Mukala K; Haavanlammi K
    Forensic Sci Int; 2008 Jan; 174(2-3):95-8. PubMed ID: 17498899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing substance use disorders in resident physicians.
    Benzer DG
    J Am Osteopath Assoc; 1993 Feb; 93(2):217-20. PubMed ID: 8240473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of drug prevention system development in Romania and its impact on youth drug consumption trends, 1995-2005.
    Dégi CL
    Drug Alcohol Rev; 2009 Jul; 28(4):419-25. PubMed ID: 19594796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surveillance groups and occupational phisicians for prevention and security in work environment: legal aspects].
    Aceto A
    G Ital Med Lav Ergon; 2006; 28(3):309-12. PubMed ID: 17144424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective.
    Wright C; Schnoll S; Bernstein D
    Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methodology of risk assessment by the occupational physician at the light of new legislative rules].
    Bergamaschi A; Pietroiusti A; Gianello G; Magrini A
    G Ital Med Lav Ergon; 2008; 30(3 Suppl):101-3. PubMed ID: 19288798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Collaboration between occupational doctors in the public prevention services and qualified occupational doctors: description of an experience in the sandstone sector of Alto Mugello].
    Faina PL; Molinaro F; Bolognesi R; Pristerà M; Mignani G
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):425-7. PubMed ID: 18409759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Occupational physicians' new attributions and responsibilities].
    Corda R; Borchini R; Taborelli S; Borsani A; Ferrario MM
    Med Lav; 2007; 98(6):475-81. PubMed ID: 18041467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral fluid testing: six considerations.
    Masterson LH
    Occup Health Saf; 2003 Aug; 72(8):78-80, 89. PubMed ID: 12945510
    [No Abstract]   [Full Text] [Related]  

  • 35. Enabling alcohol and drug abuse in the workplace.
    Nebr Nurse; 2009; 42(3):7. PubMed ID: 19771936
    [No Abstract]   [Full Text] [Related]  

  • 36. A review of guidelines for collaboration in substance misuse management.
    Van Royen K; Remmen R; Vanmeerbeek M; Godderis L; Mairiaux P; Peremans L
    Occup Med (Lond); 2013 Sep; 63(6):445-7. PubMed ID: 23881120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protection from cancerogenic and mutagenic agents in the light of the legislative decree n. 66 of February 22, 2000].
    Brusoni D
    G Ital Med Lav Ergon; 2001; 23(4):454-60. PubMed ID: 11758150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Work and alcohol abuse: the issues].
    Persechino B; Iavicoli S
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):510-3. PubMed ID: 18409803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urinary evaluations of drug consumption among workers having high risk of accident: technical difficulties, limits and possibilities of increasing efficacy of the law].
    D'Orso MI; Grosso D; Colli M; Gironi A; Riva MA; Cesana G
    G Ital Med Lav Ergon; 2012; 34(3 Suppl):756-8. PubMed ID: 23405771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cannabis and safety of work. Evolution of its detection within the controls of narcotics since 2004 to the SNCF].
    Ricordel I; Wenzek M
    Ann Pharm Fr; 2008 Aug; 66(4):255-60. PubMed ID: 18847573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.